Wang et al. found that sanguinarine promotes hepatocellular carcinoma by inhibiting the expression of Bcl-2 and promoting the expression of Bax and caspase-3 via upregulation of IGFBP3 expression [28]. The gene discussed is BAX; the disease is hepatocellular carcinoma.